Molecular mechanisms behind clinical benefits of intensive insulin therapy during critical illness: Glucose versus insulin

Best Practice and Research: Clinical Anaesthesiology

Volumn 23, Issue 4, 2009, Pages 449-459

  Vanhorebeek, Ilse ^a   Langouche, Lies ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

critical illness; glucose toxicity; insulin resistance; intensive insulin therapy

Indexed keywords

GLUCOSE; INSULIN;

ACUTE DISEASE; BIOSYNTHESIS; BURN; CLINICAL TRIAL; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DRUG EFFECT; DRUG EFFICACY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENERGY METABOLISM; GLUCOGENESIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXIA; INFECTION PREVENTION; INNATE IMMUNITY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; INTENSIVE CARE; LIPID METABOLISM; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTENSIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS, PHYSIOLOGICAL; SURVIVAL RATE;

EID: 70649095267     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.08.008     Document Type: Review

References (111)

1. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Critical Care Clinics 17 (2001) 107-124
2. Vanhorebeek I., Langouche L., and Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 132 (2007) 268-278
3. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine 345 (2001) 1359-1367
4. Ingels C., Debaveye Y., Milants I., et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. European Heart Journal 27 (2006) 2716-2724
5. Van den Berghe G., Schoonheydt K., Becx P., et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 (2005) 1348-1353
6. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354 (2006) 449-461
7. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373 (2009) 547-556
8. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (2006) 3151-3159
9. Hermans G., Wilmer A., Meersseman W., et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. American Journal of Respiratory and Critical Care Medicine 175 (2007) 480-489
10. Grey N.J., and Perdrizet G.A. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine Practice 10 Suppl. 2 (2004) 46-52
11. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings 79 (2004) 992-1000
12. Furnary A.P., and Wu Y. Eliminating the diabetic disadvantage: the Portland Diabetic Project. Seminars in Thoracic and Cardiovascular Surgery 18 (2006) 302-308
13. Reed C.C., Stewart R.M., Sherman M., et al. Intensive insulin protocol improves glucose control and is associated with a reduction in intensive care unit mortality. Journal of American College of Surgeons 204 (2007) 1048-1054
14. Bilotta F., Spinelli A., Giovannini F., et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Journal of Neurosurgical Anesthesiology 19 (2007) 156-160
15. Lecomte P., Van Vlem B., Coddens J., et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Critical Care (London, England) 12 (2008) R154
16. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 360 (2009) 1283-1297
17. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 358 (2008) 125-139
18. Van den Berghe G., Schetz M., Vlasselaers D., et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?. The Journal of Clinical Endocrinology and Metabolism 94 (2009) 3163-3170
19. Van den Berghe G., Mesotten D., and Vanhorebeek I. Intensive insulin therapy in the intensive care unit. Canadian Medical Association Journal 180 (2009) 799-800
20. Inzucchi S.E., and Siegel M.D. Glucose control in the ICU-how tight is too tight?. The New England Journal of Medicine 360 (2009) 1346-1349
21. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal 180 (2009) 821-827
22. Pittas A.G., Siegel R.D., and Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN Journal of Parenteral and Enteral Nutrition 30 (2006) 164-172
23. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Critical Care Medicine 31 (2003) 359-366
24. Van den Berghe G., Wouters P., Weekers F., et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. Journal of Clinical Endocrinology and Metabolism 84 (1999) 1311-1323
25. Van den Berghe G., Baxter R.C., Weekers F., et al. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. Journal of Clinical Endocrinology and Metabolism 85 (2000) 183-192
26. Mesotten D., Delhanty P.J., Vanderhoydonc F., et al. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. Journal of Clinical Endocrinology and Metabolism 87 (2002) 5516-5523
27. Watt M.J., Howlett K.F., Febbraio M.A., et al. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. The Journal of Physiology 534 (2001) 269-278
28. Wolfe R.R., Durkot M.J., Allsop J.R., and Burke J.F. Glucose metabolism in severely burned patients. Metabolism 28 (1979) 1031-1039
29. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. The New England Journal of Medicine 317 (1987) 403-408
30. Virkamaki A., and Yki-Jarvinen H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134 (1994) 2072-2078
31. Stephens J.M., Bagby G.J., Pekala P.H., et al. Differential regulation of glucose transporter gene expression in adipose tissue or septic rats. Biochemical and Biophysical Research 183 (1992) 417-422
32. Virkamaki A., Ueki K., and Kahn C.R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. The Journal of Clinical Investigation 103 (1999) 931-943
33. Langouche L., Vander Perre S., Wouters P.J., et al. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. Journal of Clinical Endocrinology and Metabolism 92 (2007) 3890-3897
34. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. Journal of Clinical Endocrinology and Metabolism 89 (2004) 219-226
35. Mesotten D., Wouters P.J., Peeters R.P., et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. Journal of Clinical Endocrinology and Metabolism 89 (2004) 3105-3113
36. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic Proceedings 78 (2003) 1471-1478
37. Langouche L., Meersseman W., Vander Perre S., et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients. Critical Care Medicine 36 (2008) 1475-1480
38. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes 55 (2006) 1096-1105
39. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
40. Singer M., and Brealey D. Mitochondrial dysfunction in sepsis. Biochemical Society Symposis 66 (1999) 149-166
41. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 (2002) 219-223
42. Brealey D., Karyampudi S., Jacques T.S., et al. Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 286 (2004) R491-R497
43. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation 115 (2005) 2277-2286
44. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
45. Siroen M.P., van Leeuwen P.A., Nijveldt R.J., et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?. Critical Care Medicine 33 (2005) 504-510
46. Ellger B., Langouche L., Richir M., et al. Modulation of regional nitric oxide metabolism: blood glucose control or insulin?. Intensive Care Medicine 34 (2008) 1525-1533
47. Ellger B., Richir M.C., van Leeuwen P.A., et al. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology 149 (2008) 3148-3157
48. Vanhorebeek I., Ellger B., De Vos R., et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Critical Care Medicine 37 (2009) 1355-1364
49. Vanhorebeek I., Gunst J., Ellger B., et al. Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney International 76 (2009) 512-520
50. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
51. Gore D.C., Jahoor F., Hibbert J.M., and DeMaria E.J. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Annals of Surgery 224 (1996) 97-102
52. Revelly J.P., Tappy L., Martinez A., et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Critical Care Medicine 33 (2005) 2235-2240
53. Thornalley P.J. Modification of the glyoxalase system in human red blood cells by glucose in vitro. Biochemical Journal 254 (1988) 751-755
54. Berlanga J., Cibrian D., Guillen I., et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clinical Science (London) 109 (2005) 83-95
55. Rosca M.G., Monnier V.M., Szweda L.I., and Weiss M.F. Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. American Journal of Physiology. Renal Physiology 283 (2002) F52-F59
56. Shangari N., Bruce W.R., Poon R., and O'Brien P.J. Toxicity of glyoxals-role of oxidative stress, metabolic detoxification and thiamine deficiency. Biochemical Society Transactions 31 (2003) 1390-1393
57. Rosca M.G., Mustata T.G., Kinter M.T., et al. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. American Journal of Physiology. Renal Physiology 289 (2005) F420-F430
58. Grune T., and Berger M.M. Markers of oxidative stress in ICU clinical settings: present and future. Current Opinion in Clinical Nutrition and Metabolic Care 10 (2007) 712-717
59. Eaton S. The biochemical basis of antioxidant therapy in critical illness. Proceedings of the Nutrition Society 65 (2006) 242-249
60. Pacher P., and Szabo C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxidants & Redox Signaling 7 (2005) 1568-1580
61. Hunt J.V., Dean R.T., and Wolff S.P. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochemical Journal 256 (1988) 205-212
62. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Current Opinion in Clinical Nutrition and Metabolic Care 5 (2002) 561-568
63. Suh S.W., Gum E.T., Hamby A.M., et al. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. The Journal of Clinical Investigation 117 (2007) 910-918
64. West I.C. Radicals and oxidative stress in diabetes. Diabetic Medicine 17 (2000) 171-180
65. Aulak K.S., Koeck T., Crabb J.W., and Stuehr D.J. Dynamics of protein nitration in cells and mitochondria. American Journal of Physiology. Heart and Circulatory Physiology 286 (2004) H30-H38
66. Frost M.T., Wang Q., Moncada S., and Singer M. Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 288 (2005) R394-R400
67. Turina M., Fry D.E., and Polk Jr. H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Critical Care Medicine 33 (2005) 1624-1633
68. Nielson C.P., and Hindson D.A. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro. Diabetes 38 (1989) 1031-1035
69. Perner A., Nielsen S.E., and Rask-Madsen J. High glucose impairs superoxide production from isolated blood neutrophils. Intensive Care Medicine 29 (2003) 642-645
70. Rassias A.J., Marrin C.A., Arruda J., et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesthesia & Analgesia 88 (1999) 1011-1016
71. Black C.T., Hennessey P.J., and Andrassy R.J. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. The Journal of Trauma 30 (1990) 830-832
72. Furnary A.P., Zerr K.J., Grunkemeier G.L., and Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Annals of Thoracic Surgery 67 (1999) 352-360
73. Pozzilli P., and Leslie R.D. Infections and diabetes: mechanisms and prospects for prevention. Diabetic Medicine 11 (1994) 935-941
74. Hansen T.K., Thiel S., Wouters P.J., et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. Journal of Clinical Endocrinology and Metabolism 88 (2003) 1082-1088
75. Weekers F., Van Herck E., Coopmans W., et al. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 143 (2002) 764-774
76. Weekers F., Michalaki M., Coopmans W., et al. Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. Endocrinology 145 (2004) 205-213
77. Meigs J.B., Mittleman M.A., Nathan D.M., et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. Journal of American Medical Association 283 (2000) 221-228
78. Nordt T.K., Sawa H., Fujii S., and Sobel B.E. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo. Circulation 91 (1995) 764-770
79. Stegenga M.E., van der Crabben S.N., Levi M., et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55 (2006) 1807-1812
80. Vaidyula V.R., Rao A.K., Mozzoli M., et al. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55 (2006) 202-208
81. Aljada A., and Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49 (2000) 147-150
82. Dandona P., Aljada A., Mohanty P., et al. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26 (2003) 3310-3314
83. Dandona P., Aljada A., Mohanty P., et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. Journal of Clinical Endocrinology and Metabolism 86 (2001) 3257-3265
84. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends in Immunology 25 (2004) 4-7
85. Aljada A., Ghanim H., Mohanty P., et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. Journal of Clinical Endocrinology and Metabolism 87 (2002) 1419-1422
86. Savioli M., Cugno M., Polli F., et al. Tight glycemic control may favor fibrinolysis in patients with sepsis. Critical Care Medicine 37 (2009) 424-431
87. Agus M.S., Javid P.J., Ryan D.P., and Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. Journal of Pediatric Surgery 39 (2004) 839-844
88. Gore D.C., Wolf S.E., Sanford A.P., et al. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. American Journal of Physiology. Endocrinology and Metabolism 286 (2004) E529-E534
89. Vanhorebeek I., and Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Current Opinion in Pharmacology 4 (2004) 621-628
90. Weekers F., Giulietti A.P., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
91. Solomon V., Madihally S., Yarmush M., and Toner M. Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. The Journal of Surgical Research 93 (2000) 120-126
92. Flakoll P.J., Hill J.O., and Abumrad N.N. Acute hyperglycemia enhances proteolysis in normal man. American Journal of Physiology 265 (1993) E715-E721
93. Gore D.C., Chinkes D.L., Hart D.W., et al. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Critical Care Medicine 30 (2002) 2438-2442
94. Sodi-Pallares D., Testelli M.R., Fishleder B.L., et al. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. American Journal of Cardiology 9 (1962) 166-181
95. Das U.N. Insulin: an endogenous cardioprotector. Current Opinion in Critical Care 9 (2003) 375-383
96. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. Journal of the American College of Cardiology 26 (1995) 57-65
97. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. European Heart Journal 26 (2005) 650-661
98. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Journal of American Medical Association 293 (2005) 437-446
99. Gao F., Gao E., Yue T.L., et al. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 105 (2002) 1497-1502
100. Gray C.S., Hildreth A.J., Sandercock P.A., et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurology 6 (2007) 397-406
101. Carpentier Y.A., and Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Current Opinion in Clinical Nutrition and Metabolic Care 5 (2002) 153-158
102. Lanza-Jacoby S., Wong S.H., Tabares A., et al. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochimica et Biophysica Acta 1124 (1992) 233-240
103. Jeschke M.G., Klein D., and Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Annals of Surgery 239 (2004) 553-560
104. Harris H.W., Grunfeld C., Feingold K.R., and Rapp J.H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. The Journal of Clinical Investigation 86 (1990) 696-702
105. Garcia-Marin J.J., Villanueva G.R., and Esteller A. Diabetes-induced cholestasis in the rat: possible role of hyperglycemia and hypoinsulinemia. Hepatology 8 (1988) 332-340
106. Gielkens H.A., Lam W.F., Coenraad M., et al. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. Journal of Hepatology 28 (1998) 595-602
107. Nakeeb A., Comuzzie A.G., Al-Azzawi H., et al. Insulin resistance causes human gallbladder dysmotility. Journal of Gastrointestinal Surgery 10 (2006) 940-948
108. Mesotten D., Wauters J., Van den Berghe G., et al. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. Journal of Clinical Endocrinology and Metabolism (2009)
109. Fernandez-Real J.M., Pugeat M., Emptoz-Bonneton A., and Ricart W. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance. Metabolism 50 (2001) 1248-1252
110. Vanhorebeek I., Peeters R.P., Vander Perre S., et al. Cortisol response to critical illness: effect of intensive insulin therapy. Journal of Clinical Endocrinology and Metabolism 91 (2006) 3803-3813
111. Peeters R.P., Hagendorf A., Vanhorebeek I., et al. Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Clinical Endocrinology (Oxford) 71 (2009) 145-153